Ryan Richardson

Ryan Richardson is an accomplished executive with extensive experience in healthcare strategy and corporate development. Currently serving as an Executive Board Member and Chief Strategy Officer at BioNTech SE since September 2018, Ryan also holds influential roles as a Board Observer at Crescendo Biologics Limited, Chair of the Board of Directors at InstaDeep Ltd, and Visiting Professor in Practice at The London School of Economics and Political Science. Prior experience includes significant positions at J.P. Morgan as Executive Director in Healthcare Investment Banking and co-founding Quantitative Insights, where Ryan was instrumental in achieving FDA approval for the QuantX™ Advanced system. Educational credentials include an MBA from The University of Chicago Booth School of Business, a Master of Science in Health Policy and Economics from The London School of Economics and Political Science, and a Bachelor of Science in Biology from The University of Kansas.